+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of MDS with Thalidomide, FTI anti-TNF and HDAC inhibitors



Treatment of MDS with Thalidomide, FTI anti-TNF and HDAC inhibitors



Leukemia Research 27(Supplement 1): S103




(PDF emailed within 1 workday: $29.90)

Accession: 035980529

Download citation: RISBibTeXText


Related references

HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). Pancreatology 12(2): 146-155, 2012

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites. International Journal for Parasitology. Drugs and Drug Resistance 5(3): 117-126, 2015

Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat. Plos One 11(6): E0156421-E0156421, 2016

An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Chemico-Biological Interactions 253: 112-124, 2016

Design and properties of functional zwitterions derived from ionic liquids. Physical Chemistry Chemical Physics, 2018

HDAC Inhibitors as Novel Anti-Cancer Therapeutics. Recent Patents on Anti-Cancer Drug Discovery 10(2): 145-162, 2016

A new class of anti-cancer drugs: HDAC-inhibitors. I Supplementi di Tumori 1(4): S66-S66, 2002

Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes. Biochimica et Biophysica Acta 1834(1): 317-328, 2013

HDAC inhibitors: a potential new category of anti-tumor agents. Cellular & Molecular Immunology 4(5): 337-343, 2007

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. Urologic Oncology 31(8): 1770-1779, 2014

Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions. Tumour Biology 35(1): 61-71, 2014

Identification of HDAC Inhibitors Using a Cell-Based HDAC I/II Assay. Journal of Biomolecular Screening 21(6): 643-652, 2016

Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. Journal of Neuroscience 34(43): 14328-14337, 2015

Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity. Bioorganic & Medicinal Chemistry Letters 19(11): 3023-3026, 2009

Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production. Plos One 8(8): E70939-E70939, 2014